Master Acute Tubular Necrosis with Picmonic for Medicine

Ischemic ATN occurs when renal blood flow is significantly reduced, leading to hypoxia and necrosis of tubular epithelial cells. Common scenarios include severe hypotension from sepsis, hemorrhage, or shock, and surgical procedures requiring renal artery clamping. High-yield USMLE points include that the proximal tubule and thick ascending limb of the loop of Henle are most susceptible due to high metabolic demands.

Nephrotoxic ATN arises from direct tubular epithelial cell injury by substances such as aminoglycosides, radiocontrast dyes, NSAIDs, amphotericin B, and myoglobin from rhabdomyolysis. The proximal tubule is especially affected due to high reabsorptive activity. USMLE high-yield point: Uric acid nephropathy and ethylene glycol toxicity can also cause ATN.

Urine microscopy shows granular casts composed of sloughed necrotic tubular cells. These casts are muddy brown in color, which is a classic diagnostic clue for ATN. USMLE high-yield tip: Seeing “muddy brown casts” helps differentiate ATN from pre-renal AKI, which usually shows hyaline casts.

ATN is classified as intrinsic AKI, where kidney injury originates within the renal tissue itself. Patients go through an oliguric phase with low urine output, followed by a polyuric recovery phase. USMLE high-yield note: intrinsic AKI is differentiated from pre-renal AKI by FeNa >2% and urine osmolality <350 mOsm/kg.

The oliguric phase lasts ~1-2 weeks and is marked by urine output <400 mL/day. Patients may develop volume overload, hypertension, hyperkalemia, metabolic acidosis, and uremia. Mortality is higher during this phase if untreated.

Due to impaired hydrogen ion secretion and decreased bicarbonate reabsorption, patients develop non-anion gap metabolic acidosis during the oliguric phase. Severe uremia may also contribute to systemic symptoms like confusion and nausea.

Inability to excrete potassium during the oliguric phase leads to hyperkalemia, which can cause peaked T waves and life-threatening arrhythmias on ECG. USMLE high-yield: monitor K+ closely in AKI patients.

ATN causes accumulation of urea and creatinine due to reduced glomerular filtration. Fractional excretion of sodium (FeNa) is >2%, distinguishing ATN from pre-renal AKI, where FeNa is <1%.

During recovery, patients may develop polyuria due to impaired tubular concentrating ability. Urine output can exceed 3 L/day, leading to risk of volume depletion and electrolyte loss.

In this phase, the previously elevated BUN and creatinine levels will begin to decrease.

Potassium wasting during the polyuric phase can lead to hypokalemia, requiring careful electrolyte monitoring and supplementation.

Management of ATN is primarily supportive, focusing on correction of the underlying cause (ischemia or nephrotoxins), fluid and electrolyte balance, and monitoring for complications. Dialysis may be indicated for severe uremia, refractory hyperkalemia, or fluid overload. Important tips include avoiding nephrotoxins, maintaining euvolemia, and recognizing indications for renal replacement therapy.